HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$25.66
Day range
$24.36 - $25.40
Year range
$18.92 - $81.86
Market cap
2.81B USD
Avg Volume
4.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Q1 earnings report for Viking Therapeutics
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.47M | 62.79% |
Net income | -45.63M | -66.80% |
Net profit margin | — | — |
Earnings per share | -0.41 | -57.69% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | 20.08M | -40.30% |
Total equity | — | — |
Shares outstanding | 111.57M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -45.63M | -66.80% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2012
Website
Employees
36
